New drug regimen for TB patients

They will be given fixed drug combinations on a daily basis

October 26, 2017 10:01 pm | Updated 10:01 pm IST - Puducherry

 Better care:  Health Minister Malladi Krishna Rao distributing medicines to tuberculosis patients at an event held in Puducherry .

Better care: Health Minister Malladi Krishna Rao distributing medicines to tuberculosis patients at an event held in Puducherry .

Health Minister Malladi Krishna Rao on Wednesday inaugurated the daily regimen of administering medication to tuberculosis patients under the Revised National TB Control Programme at the Government General Hospital here.

According to a release, under the new daily drug regimen, TB patients will be given fixed drug combinations (FDCs) — two to five tablets on a daily basis. The government was so far following the intermittent regimen in which the patient was given seven pills on alternate days.

Under the new regimen, the drugs will also be administered in a more scientific manner according to the patient’s weight. Hence, side effects of the drugs will be less and tolerability will be better.

The health department will administer one month of drugs to each patient and will also ensure Directly Observed Treatment (DOT) strategy by increasing the supervision and monitoring. TB will be curable by following the daily regimen for six to eight months.

With one-fourth of the global TB cases reported in India, the disease still remains a major challenge. As many as 27 lakh TB patients are diagnosed every year including 1,400 in Puducherry alone.

The introduction of the daily regimen is expected to improve the treatment adherence and reduction in relapse rate. K.V. Raman, Director of Health Services and T. Kalimuthu, Mission Director, participated.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.